Zerbaxa

Zerbaxa combines tazobactam and ceftolozane, an intravenous antibiotic used to treat bacterial infections. It targets resistant strains in urinary tract and intra-abdominal infections. This combination is prescribed when other treatments may not be effective. Always follow healthcare provider guidance.

Zerbaxa is used to treat certain bacterial infections, including complicated urinary tract infections and complicated intra-abdominal infections. It may also be prescribed for hospital-acquired pneumonia when other options are limited. The medication works by stopping bacterial growth. It is not effective against viral infections like colds or flu.

Zerbaxa works systemically to reduce infection symptoms such as fever, pain, or swelling. Patients may notice improved energy levels and reduced discomfort as the infection clears. It does not provide immediate relief for all symptoms and requires full course completion. Individual responses vary based on infection type and severity.

Zerbaxa is administered under medical supervision, typically in a clinical setting. Patients should inform their healthcare provider of allergies, especially to penicillin or cephalosporins. Hydration and monitoring for side effects are important during treatment. Do not use leftover medication for future infections without consulting a doctor.

Zerbaxa may interact with other medications, including certain blood thinners or diuretics. Alcohol use during treatment is generally discouraged. Always disclose all current medications to your healthcare provider before starting Zerbaxa. Probenecid may affect how Zerbaxa is processed in the body.